Assessment of the Effects of Early Proprioceptive Stimulations in Patients With Spinal Cord Injury (Tetra-Mouv)

October 15, 2021 updated by: Assistance Publique - Hôpitaux de Paris

Assessment of the Effects of Early Proprioceptive Stimulations in Patients With Spinal Cord Injury : a Randomized Controlled Trial

"Spinal cord injury (SCI) is a dramatic event resulting in a long-term handicap. Appropriate care from admission to the intensive care unit (ICU) is a key element not only for the survival of these patients but also to promote their recovery. Moreover, the studies on natural history of SCI have shown that most of the recovery occurs within the first 3 to 6 months post-injury. This period is therefore crucial for these patients. However, the environment of the ICU and the acute condition of the patients limit the rehabilitation possibilities. In such a context, functional proprioceptive stimulations (Vibramoov™ system, Techno Concept, France) could be a tool of interest.

By using tendon vibrations, the Vibramoov™ system allows to reproduce the proprioceptive signatures of cyclic movements such as walking. Some studies have already demonstrated the benefits of proprioceptive vibrations. However, so far, these benefits have only been studied at the chronic stage of neurological diseases.

The investigators hypothesized that early functional proprioceptive stimulations (FPS) may reduce spasticity and promote sensorimotor recovery in tetraplegic and high paraplegic patients.

To test their hypothesis, the investigators conduct a randomized controlled trial on 40 patients with traumatic SCI. These patients will be stratified into two groups according to the completeness of their lesion. Every patient will be included within ten days post-injury and receive either FPS, either sham stimulations to the joints of the lower limbs, 4 times a week during 8 weeks. the primary outcome measures will assess spasticity. the investigators also assess sensorimotor recovery, pain, muscle wasting, cognitive impairment and functional status. "

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Le Kremlin-Bicêtre, France, 94270
        • Recruiting
        • Bicetre Hospital
        • Contact:
        • Principal Investigator:
          • Bernard Vigué, MD PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • • Traumatic Spinal Cord Injury at or above level T6

    • Age ≥ 18 years old
    • No pregnancy
    • Not being under guardianship
    • Be affiliated to the French social security system

Exclusion Criteria:

  • Orthopedic lesions or any medical condition that prevent the implementation of the protocol within ten days post-injury
  • Severe brain injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement.
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement.
Sham Comparator: Control group
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations.
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in the modified Ashworth scale (MAS)
Time Frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
The MAS enables to assess spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity)
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Changes in the angles of the muscle reaction in the modified Tardieu scale (MTS)
Time Frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
The MTS enables to assess the severity of spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (The outcome is reported in degree, from 0 to 180 degrees, higher values represent a higher dynamic component of spasticity)
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Changes in the quality of the muscle reaction in the modified Tardieu scale (MTS)
Time Frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity)
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Changes in the Spinal cord assessment tool for spastic reflexes (SCATS)
Time Frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
This score enables to asses global spasticity (Score range from 0 to 18, higher values represent a higher degree of spasticity)
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in the visual analog scale for the auto-assessment of problematic spasticity
Time Frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Score range from 0 to 100, higher values represent a higher degree of problematic spasticity.
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Changes in the visual analog scale for the auto-assessment of pain
Time Frame: Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury
Score range from 0 to 100, higher values represent a higher intensity of pain.
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury
Changes in the International standards for neurological classification of spinal cord injury (ISNCSCI) score
Time Frame: At inclusion, and at one week, one month, 2 months, 6 months and 1 year after the injury.
This score enables to assess sensorimotor recovery (Score range from 0 to 324, higher values represent a better outcome)
At inclusion, and at one week, one month, 2 months, 6 months and 1 year after the injury.
Changes in the quadriceps muscle thickness
Time Frame: At inclusion, then twice a week during the first month, and at 2 months, 6 months and 1 year after the injury
"Measured with ultrasound, average of two measures (at the border between the lower third and upper two-thirds between the anterior superior iliac spine and the upper pole of the patella, and at the midpoint between the anterior superior iliac spine and the upper pole of the patella) (Measure in centimeters, higher values represent a better outcome)"
At inclusion, then twice a week during the first month, and at 2 months, 6 months and 1 year after the injury
Changes in the nitrogen balance,
Time Frame: Every 48 hours during the first two weeks, and then once a week for six weeks
Marker of protein losses (Measure in mmol/L, lower values represent a better outcome)
Every 48 hours during the first two weeks, and then once a week for six weeks
Number of days between the SCI and the verticalization at 45°
Time Frame: Verticalization is attempted progressively 3 times a week during the 8 weeks of treatment.
The attempt is successful if the position is maintained for 5 minutes without adverse effect. The verticalization protocol will remain the same as the one commonly used in the ICU. According to this protocol, verticalization will be progressive and mean blood pressure will be monitored continuously. The attempt is stopped if the patient feels unwell (signs of intolerance) or if the mean blood pressure drops by more than 20% (Measure in days, higher values represent a lower outcome)
Verticalization is attempted progressively 3 times a week during the 8 weeks of treatment.
Number of days between the SCI and the verticalization at 70°
Time Frame: Verticalization is attempted progressively 3 times a week during the 8 weeks of treatment.
The attempt is successful if the position is maintained for 5 minutes without adverse effect. The verticalization protocol will remain the same as the one commonly used in the ICU. According to this protocol, verticalization will be progressive and mean blood pressure will be monitored continuously. The attempt is stopped if the patient feels unwell (signs of intolerance) or if the mean blood pressure drops by more than 20% (Measure in days, higher values represent a lower outcome)
Verticalization is attempted progressively 3 times a week during the 8 weeks of treatment.
Changes in the Spinal cord independence measure (SCIM)
Time Frame: At 2 months, 6 months and 1 year after the injury
This measure enables to assess functional status (Score range from 0 to 100, higher values represent a better outcome)
At 2 months, 6 months and 1 year after the injury
Changes in the Montreal cognitive assessment (MoCA)
Time Frame: Up to 1 month, then at 2 months and 1 year after the injury
This measure enables to assess cognitive impairments (Score range from 0 to 30, higher values represent a better outcome)
Up to 1 month, then at 2 months and 1 year after the injury
Changes in the time to complete the bells cancellation test to assess cognitive impairments
Time Frame: Up to 1 month, then at 2 months and 1 year after the injury
This measure enables to assess cognitive impairments (Measure in minutes and seconds, lower values represent a better outcome)
Up to 1 month, then at 2 months and 1 year after the injury
Changes in the number of omissions in the bells cancellation test to assess cognitive impairments
Time Frame: Up to 1 month, then at 2 months and 1 year after the injury
This measure enables to assess cognitive impairments (Lower values represent a better outcome)
Up to 1 month, then at 2 months and 1 year after the injury
Changes in the digit span test to assess cognitive impairments
Time Frame: Up to 1 month, then at 2 months and 1 year after the injury
This measure enables to assess cognitive impairments (Higher values represent a better outcome)
Up to 1 month, then at 2 months and 1 year after the injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bernard VIGUE, APHP

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 20, 2021

Primary Completion (Anticipated)

September 20, 2024

Study Completion (Anticipated)

September 20, 2024

Study Registration Dates

First Submitted

September 22, 2021

First Submitted That Met QC Criteria

October 15, 2021

First Posted (Actual)

October 26, 2021

Study Record Updates

Last Update Posted (Actual)

October 26, 2021

Last Update Submitted That Met QC Criteria

October 15, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on Proprioceptive stimulations

Subscribe